Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 3 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar portefeuille (99.67) Submitted: 12/18/2012 10:53:05 PM : Outperform Start Price: $41.92 SLXP Score: +115.93

http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.

Featured Broker Partners


Advertisement